Pharmacovigilance Adverse Drug Reactions reporting: Knowledge, Attitude and Practice study among Health Professionals in Yaoundé, Cameroon

The term pharmacovigilance means all scientific and data gathering activities relating to the detection, assessment, and understanding of adverse events. These activities are undertaken with the goal of identifying adverse events and understanding, their nature, frequency, and potential risk factors [1]. In developing countries there is a gap of information on data outcome of adverse reaction of most approved drugs in the market. This may be due to postmarketing sensitization by the medical delegates or by the medics administering the drugs to inform patients to report any problems linked to the drug during administration [1,2]. There is therefore the need to understand the knowledge gap in pharmacovigilance among patients and stake holders of drug use. Post-marketing surveillance, phamacovigilance and adverse event/adverse experience are related to any untoward medical occurrence that may present during treatment with a pharmaceutical product but which does not necessarily have a causal relationship with this treatment [3]. Reported information on a possible causal relationship between an adverse event and a drug, the relationship being unknown or incompletely documented previously in most cases more than a single report is required to generate a signal, depending upon the seriousness of the event and the quality of the information [3,4]. We may have to trace back the need for pharmacovigilance studies from Volume 4 Issue 6 2017